CKMT2-AS1

Across TCGA pan-cancer cohorts, CKMT2-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated CKMT2-AS1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CKMT2-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CKMT2-AS1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and BRCA show a favorable association.

KIRP, THCA, and ACC are the cancer types where CKMT2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.798	0.929	.002	40	view →
THCA	OS	Quartile	II,III,IV	0.869	0.989	.008	36	view →
ACC	OS	Median	All	0.735	1.000	.003	34	view →
KIRC	DFS	Quartile	All	0.885	0.635	<.001	27	view →
BRCA	DFS	Quartile	IV	0.934	0.317	.003	21	view →
READ	DFS	Median	All	0.783	0.367	.011	20	view →
UCS	DFS	Median	IV	0.835	0.490	.031	18	view →
SKCM	OS	Tertile	IV	0.267	0.693	.005	9	view →
SARC	OS	Median	All	0.877	0.767	.009	7	view →
MESO	OS	Median	III,IV	0.718	0.355	.025	6	view →
CESC	OS	Tertile	II,III,IV	0.860	0.650	.017	6	view →
LUAD	DFS	Tertile	All	0.845	0.701	.009	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

CKMT2-AS1–KIRP (DFS)

Open the KIRP breakdown →